Acetic Acid → HCID 136248870, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C:14]2[NH:23][C:22](=[O:24])[C:21]3[C:16](=[CH:17][C:18]([O:27][CH3:28])=[CH:19][C:20]=3[O:25][CH3:26])[N:15]=2)[CH:5]=[C:6]([N:8]2[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]2)[CH:7]=1.[CH3:29][C:30]([CH3:32])=O.C([O-])(=O)C.[Na+].C(O)(=O)C.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>ClCCCl.CO>[Cl:1][C:2]1[CH:3]=[C:4]([C:14]2[NH:23][C:22](=[O:24])[C:21]3[C:16](=[CH:17][C:18]([O:27][CH3:28])=[CH:19][C:20]=3[O:25][CH3:26])[N:15]=2)[CH:5]=[C:6]([N:8]2[CH2:13][CH2:12][N:11]([CH:30]([CH3:32])[CH3:29])[CH2:10][CH2:9]2)[CH:7]=1Participants
Procedure
To a solution of 2-(3-chloro-5-(piperazin-1-yl)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one (Example 31, 0.054 g, 0.14 mmol), acetone (0.060 g, 1.4 mmol), sodium acetate (0.023 g, 0.27 mmol), and acetic acid (0.16 g, 2.7 mmol) in 1,2-dichloroethane/methanol (5/5 mL) was added sodium triacetoxyborohydride (0.56 g, 2.7 mmol). The mixture was stirred at room temperature for 16 h and then concentrated. The residue was purified by silica gel chromatography eluting with 0-100% 92:7:1 CHCl3/MeOH/concentrated NH4OH in CH2Cl2. This material was further purified by reverse phase HPLC eluting with 10% to 90% CH3CN in H2O with 0.1% TFA. The product fractions were concentrated and the residue was dissolved in acetonitrile and water. The mixture was basified with concentrated NH4OH and concentrated. The residue was purified by reverse phase HPLC eluting with 10% to 90% CH3CN in H2O without TFA to afford the title compound (0.011 g, 18%) as an off-white solid: 1H NMR (500 MHz, CD3OD) δ 7.52 (s, 1H), 7.49 (d, J=1.5 Hz, 1H), 7.18 (t, J=1.5 Hz, 1H), 6.82 (d, J=2.5 Hz, 1H), 6.59 (d, J=2.5 Hz, 1H), 3.93 (s, 3H), 3.92 (s, 3H), 3.35-3.60 (br s, 4H), 2.85-3.15 (br s, 4H), 1.25-1.40 (br s, 1H), 1.23 (d, J=6.5 Hz, 6H); ESI MS m/z 443 [M+H]+.
Workup
- concentrationconcentrated
- customThe residue was purified by silica gel chromatography
- washeluting with 0-100% 92:7:1 CHCl3/MeOH/concentrated NH4OH in CH2Cl2
- customThis material was further purified by reverse phase HPLC
- washeluting with 10% to 90% CH3CN in H2O with 0.1% TFA
- concentrationThe product fractions were concentrated
- dissolutionthe residue was dissolved in acetonitrile
- concentrationconcentrated
- customThe residue was purified by reverse phase HPLC
- washeluting with 10% to 90% CH3CN in H2O without TFA
Sources & evidence
- ORD record
- ord-69b40557294345aebd94aca6cb29e7ab
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09278940B2
Reaction notes
Loading…